Vaccines, blood, antisera, toxins and cultures in   Australia

Exports In 2022, Australia exported $1.28B in Vaccines, blood, antisera, toxins and cultures, making it the 20th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 26th most exported product in Australia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Australia are: United States ($830M), New Zealand ($72.5M), Germany ($67.5M), China ($43.6M), and Vietnam ($31.5M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Australia between 2021 and 2022 were United States ($139M), New Zealand ($32.8M), and Chinese Taipei ($22.5M).

Imports In 2022, Australia imported $5.46B in Vaccines, blood, antisera, toxins and cultures, becoming the 13th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in Australia. Australia imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($1.17B), United States ($1.11B), Belgium ($548M), Switzerland ($534M), and South Korea ($472M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Australia between 2021 and 2022 were Germany ($383M), South Korea ($325M), and United States ($223M).